Literature DB >> 6144253

Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.

H Hidaka, T Endo.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6144253

Source DB:  PubMed          Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res        ISSN: 0747-7767


× No keyword cloud information.
  6 in total

Review 1.  Phosphodiesterase inhibitors.

Authors:  Victoria Boswell-Smith; Domenico Spina; Clive P Page
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 2.  Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.

Authors:  C D Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.

Authors:  G Hakim; D Fiorentini; A Falasca; M Prosdocimi; C A Rossi
Journal:  Experientia       Date:  1988-03-15

4.  The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.

Authors:  M L Reeves; B K Leigh; P J England
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

5.  Human lower oesophageal sphincter relaxation is associated with raised cyclic nucleotide content.

Authors:  M S Barnette; F C Barone; P J Fowler; M Grous; W J Price; H S Ormsbee
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

6.  {alpha}MSH and Cyclic AMP elevating agents control melanosome pH through a protein kinase A-independent mechanism.

Authors:  Yann Cheli; Flavie Luciani; Mehdi Khaled; Laurent Beuret; Karine Bille; Pierre Gounon; Jean-Paul Ortonne; Corine Bertolotto; Robert Ballotti
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.